chr11-18612423-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_194285.3(SPTY2D1):c.1777G>A(p.Asp593Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000623 in 1,444,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_194285.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTY2D1 | NM_194285.3 | c.1777G>A | p.Asp593Asn | missense_variant | 4/6 | ENST00000336349.6 | NP_919261.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTY2D1 | ENST00000336349.6 | c.1777G>A | p.Asp593Asn | missense_variant | 4/6 | 1 | NM_194285.3 | ENSP00000337991 | P1 | |
SPTY2D1 | ENST00000536336.5 | n.1909G>A | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249140Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134764
GnomAD4 exome AF: 0.00000623 AC: 9AN: 1444964Hom.: 0 Cov.: 29 AF XY: 0.00000278 AC XY: 2AN XY: 718690
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.1777G>A (p.D593N) alteration is located in exon 4 (coding exon 4) of the SPTY2D1 gene. This alteration results from a G to A substitution at nucleotide position 1777, causing the aspartic acid (D) at amino acid position 593 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at